ReviewDrug design, development and therapy2021
The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease.
Giovanni Abbruzzese et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it